Skip to content

French Travelers' Knowledge of Risk of Acquiring ESBL-PE

Poor Knowledge Among French Travelers of the Risk of Acquiring Multidrug-resistant Bacteria During Travel

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03339947
Acronym
MDR bacteria
Enrollment
191
Registered
2017-11-13
Start date
2016-01-01
Completion date
2016-06-01
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Travel Medicine

Keywords

Multidrug-resistant Enterobacteriaceae acquisition, travellers' diarrhoea, international travel

Brief summary

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to determine, among French travelers attending a consultation for travel medicine, patients level of knowledge about the risk of acquiring MRE.

Detailed description

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, The investigators aimed to assess, among persons attending a consultation for travel medicine and international vaccines, patients level of knowledge regarding the risk of acquiring MRE, preventive behaviours and the need to inform health professionals that they had recently travelled if the patients require medical care after their return. A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital, France. All adult travellers who attended this consultation between January 2016 and May 2016 and who completed the questionnaire were included in the study. The questionnaire was completed before the planned travel. The travellers answered the questionnaires before seeing the physician.

Interventions

OTHERQuestionnaire

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital * Adult who completed the questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Level of knowledge regarding multidrug resistant EnterobacteriaceaeDay 1The questionnaire was completed before the planned travel and recorded information on the patient's knowledge of the definition of multidrug resistant bacteria (MDR), knowledge of the factors associated with acquiring MDR bacteria, consumption of antibiotics during previous travel, awareness of the need to inform health professionals about the recent trip in case of health problems after return, perceived need for more information about MDR bacteria, desired source of such information. The questions about knowledge were designed to be as simple as possible, with closed answers ('yes', 'no', 'don't know')

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026